News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
VIKING GLOBAL INVESTORS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2023 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Bought 850,000 shares
@ $16, valued at
$13.6M
|
|
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Bought 1,000,000 shares
@ $29.9999, valued at
$30M
Bought 333,333 shares
@ $29.9999, valued at
$10M
|
|
| 09/09/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 80,715 shares
@ $27.2823, valued at
$2.2M
Sold 108,631 shares
@ $28.1557, valued at
$3.1M
Sold 159,026 shares
@ $29.1426, valued at
$4.6M
Sold 15,996 shares
@ $30.5875, valued at
$489.3k
Sold 111,102 shares
@ $32.2296, valued at
$3.6M
Sold 38,116 shares
@ $27.2823, valued at
$1M
Sold 51,298 shares
@ $28.1557, valued at
$1.4M
Sold 75,096 shares
@ $29.1426, valued at
$2.2M
Sold 7,554 shares
@ $30.5875, valued at
$231.1k
Sold 52,466 shares
@ $32.2296, valued at
$1.7M
Sold 312,353 shares
@ $29.8677, valued at
$9.3M
|
|
| 03/22/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on PROCEPT BioRobotics Corp|
Txns:
| Sold 1,147,205 shares
@ $29.9, valued at
$34.3M
Sold 101,795 shares
@ $29.9, valued at
$3M
|
|
| 03/04/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Disposed of 288,000,000 shares
@ $0
Acquired 288,000,000 options to buy
@ $0 |
|
| 01/13/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Converted 4,870,536 shares
@ $0
Bought 2,300,000 shares
@ $19, valued at
$43.7M
Converted 4,870,536 preferred shares
@ $0 |
|
| 01/05/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on APi Group Corp|
Txns:
| Bought 196,000 options to buy
@ $24.6, valued at
$4.8M
Bought 4,000 options to buy
@ $24.6, valued at
$98.4k
|
|
| 09/21/2021 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on PROCEPT BioRobotics Corp|
Txns:
| Converted 3,407,028 shares
@ $0
Converted 678,985 shares
@ $0
Converted 113,737 shares
@ $0
Bought 400,000 shares
@ $35, valued at
$14M
Converted 3,407,028 preferred shares
@ $0
Converted 678,985 preferred shares
@ $0
Converted 113,737 preferred shares
@ $0 |
|
| 09/03/2021 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on FIGS, Inc.|
Txns:
| Sold 157,587 shares
@ $47.28, valued at
$7.5M
Sold 42,413 shares
@ $44.92, valued at
$1.9M
|
|
| 08/02/2021 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Rallybio Corp|
Txns:
| Converted 3,388,777 shares
@ $0
Bought 806,000 shares
@ $13, valued at
$10.5M
Converted 21,578,387 options to buy
@ $0 |
|
| 12/17/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on 4D Molecular Therapeutics Inc.|
Txns:
| Converted 2,004,581 shares
@ $0
Converted 833,333 shares
@ $0
Bought 1,100,000 shares
@ $23, valued at
$25.3M
Converted 2,004,581 options to buy
@ $0
Converted 833,333 options to buy
@ $0 |
|
| 12/16/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,000,000 shares
@ $55.65, valued at
$55.7M
|
|
| 12/03/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 500,000 shares
@ $50.5, valued at
$25.3M
|
|
| 11/13/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 2,500,000 shares
@ $49.515, valued at
$123.8M
|
|
| 08/28/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Bought 80,219 shares
@ $18.838, valued at
$1.5M
Bought 100,000 shares
@ $18.987, valued at
$1.9M
|
|
| 08/25/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Bought 46,161 shares
@ $19.432, valued at
$897k
Bought 14,825 shares
@ $19.231, valued at
$285.1k
Bought 70,479 shares
@ $19.39, valued at
$1.4M
|
|
| 04/08/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Bought 725,000 shares
@ $18, valued at
$13.1M
|
|
| 01/30/2020 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 4,912,899 shares
@ $24.9763, valued at
$122.7M
|
|
| 07/12/2019 |
4
| VIKING GLOBAL INVESTORS LP (Former 10% Owner) has filed a Form 4 on Arbutus Biopharma Corp |
| 07/12/2019 |
4
| VIKING GLOBAL INVESTORS LP (Former 10% Owner) has filed a Form 4 on Axovant Gene Therapies Ltd. |
| 07/12/2019 |
4
| VIKING GLOBAL INVESTORS LP (Former 10% Owner) has filed a Form 4 on Myovant Sciences Ltd. |
| 07/12/2019 |
4
| VIKING GLOBAL INVESTORS LP (Former 10% Owner) has filed a Form 4 on Urovant Sciences Ltd. |
| 07/02/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Bought 250,000 shares
@ $20, valued at
$5M
Converted 18,908,945 shares
@ $0
Converted 15,524,350 shares
@ $0
Converted 2,007,740 shares
@ $0
Converted 290,572 shares
@ $0
Converted 18,908,945 preferred shares
@ $0
Converted 15,524,350 preferred shares
@ $0
Converted 2,007,740 preferred shares
@ $0
Converted 290,572 preferred shares
@ $0 |
|
| 06/28/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Converted 11,736,137 shares
@ $0
Converted 10,178,954 shares
@ $0
Bought 4,705,900 shares
@ $17, valued at
$80M
Converted 51,781,276 options to buy
@ $0
Converted 50,446,451 options to buy
@ $0 |
|
| 06/19/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,541 shares
@ $8.5346, valued at
$55.8k
Bought 6,706 shares
@ $8.2107, valued at
$55.1k
Bought 4,957 shares
@ $8.1693, valued at
$40.5k
|
|
| 06/14/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 7,500 shares
@ $8.2992, valued at
$62.2k
Bought 7,367 shares
@ $7.9466, valued at
$58.5k
Bought 7,144 shares
@ $7.9107, valued at
$56.5k
|
|
| 06/13/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Bought 2,424,242 shares
@ $8.25, valued at
$20M
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 7,500 shares
@ $7.5881, valued at
$56.9k
Bought 6,540 shares
@ $8.015, valued at
$52.4k
Bought 7,082 shares
@ $7.9951, valued at
$56.6k
|
|
| 06/03/2019 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,951 shares
@ $7.9726, valued at
$55.4k
Bought 300 shares
@ $8.9066, valued at
$2.7k
Bought 5,071 shares
@ $7.6991, valued at
$39k
Bought 5,424 shares
@ $7.7092, valued at
$41.8k
|
|
|
|
|